Zach Sachar
Senior Associate

Zach has several years of experience analyzing both development stage and commercial stage companies in the healthcare and life sciences industries.

Prior to joining K2HV, Zach was an Assistant Vice President on the Specialty Pharmaceuticals Equity Research team at Piper Sandler. He was responsible for conducting in-depth clinical, commercial, and financial analysis on a range of companies across the life sciences industry. Additionally, Zach has experience in strategic finance and investor relations within the healthcare industry.

Zach holds a B.S. in Biology/Neuroscience from Carnegie Mellon University.